IMR-32（人神經母細胞瘤細胞）
CBP60306
詢 價
索取STR
產品描述
產品數(shù)據庫
| I. General information | |
| Synonyms: | IMR-32 |
| Background: | The IMR-32 cell line was established by W.W. Nichols, J. Lee and S. Dwight in April, 1967 from an abdominal mass occurring in a 13-month-old Caucasian male. The tumor was diagnosed as a neuroblastoma with rare areas of organoid differentiation. |
| Species: | Homo sapiens, human |
| Tissue: | brain; derived from metastatic site: abdominal mass |
| Disease: | neuroblastoma |
| Gender: | male, 13 months, Caucasian |
| Morphology: | fibroblast; neuroblast |
| Growth Mode: | adherent |
| Doubling Time: | approximately 20 hrs. |
| DNA Profile: | Amelogenin: X,Y CSF1PO: 11,12 D13S317: 9 D16S539: 8 D5S818: 11,12 D7S820: 9,10 THO1: 7,9.3 TPOX: 11 vWA: 15 Our Cell Line Authentication Service |
| Culture Medium: |
MEM+ 10%FBS+ 1% Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP) IMR-32完全培養(yǎng)基，# CBP60306M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Comments: | Two cell types are present. Predominant is a small neuroblast-like cell.The other is a large hyaline fibroblast. IMR-32 cells may pile up and grow in patches. IMR-32 cells may not become 100% confluent. Virus Susceptibility Vesicular stomatitis, Orsay (Indiana) Vesicular stomatitis, Glasgow (Indiana) Herpes simplex virus Vaccinia virus Human Coxsackievirus B3 Human poliovirus 3 Virus Resistance {8B5AD8F2-1676-4399-B5A1-85F54726A74D} For more information, please contact us (4008-750-250). |
